Back to mobile site

KeyBanc Starts National Health Investors (NHI) at Hold; Earnings Upside From External Growth, But Concerns Remain

December 8, 2011 2:10 PM EST
Get Alerts NHI Hot Sheet
Price: $72.95 +2.36%

Rating Summary:
    8 Buy, 7 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
KeyBanc initiates coverage on National Health Investors (NYSE: NHI) with a Hold.

KeyBanc analyst says, "Our thesis: External growth upside, solid SNF credit, fairly valued. In the context of an improving economy in 2012, we expect NHI to outperform its health care REIT peers but underperform REITs overall. In our view, the Company offers investors two advantages over other health care REITs. First, we expect NHI to generate substantial earnings upside from accretive investments in 2012...Although uncertainty has recently eased somewhat, we see continued risk of additional government reimbursement and other health care spending cuts. These cuts could negatively impact NHI's property valuations and NAV, as well as the credit of its health care operator tenants."

"We are establishing 2012 and 2013 FFO estimates for NHI of $3.10 and $3.25 per share, respectively."

For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.

Shares of National Health Investors closed at $43.50 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

KeyBanc, Earnings